𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PCN56 COST OF RENAL CELL CARCINOMA TREATMENT IN PATIENTS TREATED WITH INTERFERON-ALPHA

✍ Scribed by T Purmonen; R Vuorinen; V Kataja; S Pyrhönen; P Kellokumpu-Lehtinen

Book ID
118611900
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
92 KB
Volume
12
Category
Article
ISSN
1098-3015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon-alpha antibodies in patients
Interferon-alpha antibodies in patients with renal cell carcinoma treated with recombinant interferon-alpha-2A in an adjuvant multicenter trial
✍ Otto Prümmer; Delta-P Study Group 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 657 KB

Background. Prolonged therapy with interferon (IFN) may lead to the formation of IFN antibodies. Methods. Patients with renal cell carcinoma (n = 270) with advanced localized disease were randomized after complete tumor resection to receive treatment with adjuvant recombinant IFN-alpha-2a (rIFN-a2a